Who Paid My Doc
iStent infinite Trabecular Micro-Bypass System Model iS3
Device Glaucoma
General payments
$186,728
Research payments
$165,421
Through program year 2024, $186,728 in general payments and $165,421 in research payments were reported against iStent infinite Trabecular Micro-Bypass System Model iS3 (Glaucoma).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $396 | 3 |
| 2023 | General | $186,332 | 875 |
| 2023 | Research | $165,421 | 16 |
Breakdown
Each share is of general payments naming this product in 2024.
Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2024 where a state was reported.
Records
878 general · 16 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.